Share This Post

Business Wire

EchoNous Partners with Us2.ai for Machine Learning-enabled Analysis of Heart Scans

REDMOND, Wash.–(BUSINESS WIRE)–EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements. Us2.ai’s technology received FDA approval on July 27, 2021. Us2.ai’s software is being integrated into EchoNous’s Kosmos Platform, enabling automated analysis of heart str

Share This Post